title: Quantitation of "autophagic flux" in mature skeletal muscle.
abstract: Reliable and quantitative assays to measure in vivo autophagy are essential. Currently, there are varied methods for monitoring autophagy; however, it is a challenge to measure "autophagic flux" in an in vivo model system. Conversion and subsequent degradation of the microtubule-associated protein 1 light chain 3 (MAP1-LC3/LC3) to the autophagosome associated LC3-II isoform can be evaluated by immunoblot. However, static levels of endogenous LC3-II protein may render possible misinterpretations since LC3-II levels can increase, decrease or remain unchanged in the setting of autophagic induction. Therefore, it is necessary to measure LC3-II protein levels in the presence and absence of lysomotropic agents that block the degradation of LC3-II, a technique aptly named the "autophagometer." In order to measure autophagic flux in mouse skeletal muscle, we treated animals with the microtubule depolarizing agent colchicine. Two days of 0.4 mg/kg/day intraperitoneal colchicine blocked autophagosome maturation to autolysosomes and increased LC3-II protein levels in mouse skeletal muscle by >100%. The addition of an autophagic stimulus such as dietary restriction or rapamycin led to an additional increase in LC3-II above that seen with colchicine alone. Moreover, this increase was not apparent in the absence of a "colchicine block." Using this assay, we evaluated the autophagic response in skeletal muscle upon denervation induced atrophy. Our studies highlight the feasibility of performing an "in vivo autophagometer" study using colchicine in skeletal muscle.
authors.affiliation: Department of Neurology and Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO, USA.
authors.forename: Jeong-Sun
authors.initials: JS
authors.lastname: Ju
authors.forename: Arun S
authors.initials: AS
authors.lastname: Varadhachary
authors.forename: Sara E
authors.initials: SE
authors.lastname: Miller
authors.forename: Conrad C
authors.initials: CC
authors.lastname: Weihl
mesh_terms: D000818:Animals; D018501:Antirheumatic Agents / Q000494:pharmacology; D001343:Autophagy / Q000502:physiology*; D002460:Cell Line; D002738:Chloroquine / Q000494:pharmacology; D003078:Colchicine / Q000494:pharmacology; D006801:Humans; D008297:Male; D051379:Mice; D008869:Microtubule-Associated Proteins / Q000235:genetics / Q000378:metabolism; D009121:Muscle Denervation; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D050257:Tubulin Modulators / Q000494:pharmacology; D014747:Vinblastine / Q000494:pharmacology
chemical_list: D018501:Antirheumatic Agents; C480860:Map1lc3b protein, mouse; D008869:Microtubule-Associated Proteins; D020033:Protein Isoforms; D050257:Tubulin Modulators; D014747:Vinblastine; D002738:Chloroquine; D003078:Colchicine